媒體影音報導:

1. 「大腦健康・快樂生活」系列《43》 110年10月  台北榮民總醫院一般神經科主任 傅中玲 主講 洪鈞培文教基金會

https://www.youtube.com/watch?v=oPtviai4GNw

2. 2022年0608現代華佗榮總醫師開講《淺談帕金森氏症、阿茲海默症和失智》傅中玲 主任 主講

論文發表

1. Tsai CF, Huang MH, Lin YS, Chen CY, Fuh JL*. Health-related quality of life and mild behavioral impairment in older adults without dementia. International Journal of Geriatric Psychiatry 38(9): e6003, 2023
2. Huang MH, Tsai CF, Cheng CM, Lin YS, Lee WJ, Kuo YS, Chan YLE, Fuh JL*. Predictors of emergency department visit among people with dementia in Taiwan. Archives of Gerontology and Geriatrics 101:104701, 2022
3. Chen CY, Lin YS, Lee WJ, Liao YC, Kuo YS, Yang AC, Fuh JL*. Endophenotypic Effects of the SORL1 Variant rs2298813 on Regional Brain Volume in Patients with Late-Onset Alzheimer’s Disease. Frontiers Aging Neuroscience 14:885090, 2022
4. Hsieh TJ, Lee WJ, Liao YC, Hsu CC, Fang YH, Chen TY, Lin YS, Chang IS, Wang SJ, Hsiung CA, Fuh JL*, for the Alzheimer’s Disease Neuroimaging Initiative. Association between Alzheimer’s disease genes and trajectories of cognitive function decline in Han Chinese in Taiwan. Aging 13(13): 17237-17252, 2021.
5. Hsu TW, Fuh JL*, Wang DW, Chen LF, Chang CJ, Huang WS, Wu HM, Guo WY. Disrupted metabolic connectivity in dopaminergic and cholinergic networks at different stages of dementia from 18 F-FDG PET brain persistent homology network. Sci Rep. 11(1):5396, 2021
6. Lin YS, Cheng CY, Liao YC, Hong CJ, Fuh JL*. Mutational analysis in familial Alzheimer's disease of Han Chinese in Taiwan with a predominant mutation PSEN1 p.Met146Ile. Sci Rep. 10(1):19769, 2020
7. Lee WJ, Liao YC, Wang YF, Lin YS, Wang SJ, Fuh JL*. Summative effects of vascular risk factors on the progression of Alzheimer's disease. JAGS 68 (1), 129-136, 2020
8. Tien YT, Lee WJ, Liao YC, Wang WF, Jhang KM, Wang SJ, Fuh JL*. Plasma Transthyretin as a Predictor of Amnestic Mild Cognitive Impairment Conversion to Dementia. Scientific Reports 9:18691, 2019.
9. Lin YS, Lee WJ, Wang SJ, Fuh JL*. Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease. Scientific Reports. 26;8(1):17368, 2018.
10. Lee WJ, Liao YC, Wang YF, Lin IF, Wang SJ, Fuh JL＊. Plasma MCP-1 and Cognitive Decline in Patients with Alzheimer’s Disease and Mild Cognitive Impairment: A Two-year Follow-up Study. Scientific Report 19;8(1):1280, 2018

* Correspondence author